Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Acta Diabetologica
|
November 22, 2020
One hundred years ago: the dawning of the insulin era
Massimo Porta
Journal of Evaluation in Clinical Practice
|
June 11, 2004
Is there life after evidence-based medicine?
Massimo Porta
Current Medicinal Chemistry
|
June 11, 2013
Pericyte loss in diabetic retinopathy: mechanisms and consequences
Elena Beltramo, Massimo Porta
Internal and Emergency Medicine
|
December 19, 2019
Intravitreal anti-VEGF agents and cardiovascular risk
Massimo Porta, Elio Striglia
Pharmacology & Therapeutics
|
September 17, 2004
Current approaches and perspectives in the medical treatment of diabetic retinopathy
Massimo Porta, Attilio Allione
Pediatric Endocrinology Reviews : PER
|
January 27, 2006
Diabetic retinopathy and its relevance to paediatric age. An update
Massimo Porta, Attilio Allione
Diabetes/Metabolism Research and Reviews
|
March 11, 2005
Salt and hypertension: a phylogenetic perspective
Arye Lev-Ran, Massimo Porta
Endocrine
|
January 4, 2014
The changing role of the endocrinologist in the care of patients with diabetic retinopathy
Massimo Porta, Anna Viola Taulaigo
Acta Diabetologica
|
June 6, 2021
Thiamine and diabetes: back to the future?
Elena Beltramo, Aurora Mazzeo, Massimo Porta
International Journal of Molecular Sciences
|
January 11, 2024
Release of Pro-Inflammatory/Angiogenic Factors by Retinal Microvascular Cells Is Mediated by Extracellular Vesicles Derived from M1-Activated Microglia
Elena Beltramo, Aurora Mazzeo, Massimo Porta
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Acta Diabetologica
|
November 22, 2020
One hundred years ago: the dawning of the insulin era
Massimo Porta
Journal of Evaluation in Clinical Practice
|
June 11, 2004
Is there life after evidence-based medicine?
Massimo Porta
Current Medicinal Chemistry
|
June 11, 2013
Pericyte loss in diabetic retinopathy: mechanisms and consequences
Elena Beltramo, Massimo Porta
Internal and Emergency Medicine
|
December 19, 2019
Intravitreal anti-VEGF agents and cardiovascular risk
Massimo Porta, Elio Striglia
Pharmacology & Therapeutics
|
September 17, 2004
Current approaches and perspectives in the medical treatment of diabetic retinopathy
Massimo Porta, Attilio Allione
Pediatric Endocrinology Reviews : PER
|
January 27, 2006
Diabetic retinopathy and its relevance to paediatric age. An update
Massimo Porta, Attilio Allione
Diabetes/Metabolism Research and Reviews
|
March 11, 2005
Salt and hypertension: a phylogenetic perspective
Arye Lev-Ran, Massimo Porta
Endocrine
|
January 4, 2014
The changing role of the endocrinologist in the care of patients with diabetic retinopathy
Massimo Porta, Anna Viola Taulaigo
Acta Diabetologica
|
June 6, 2021
Thiamine and diabetes: back to the future?
Elena Beltramo, Aurora Mazzeo, Massimo Porta
International Journal of Molecular Sciences
|
January 11, 2024
Release of Pro-Inflammatory/Angiogenic Factors by Retinal Microvascular Cells Is Mediated by Extracellular Vesicles Derived from M1-Activated Microglia
Elena Beltramo, Aurora Mazzeo, Massimo Porta
Page
of 10